(Q44418703)

2 December 2017

title

An association of autoantibody status and serum cytokine levels in type 1 diabetes (English)

1 reference

2 December 2017

An Association of Autoantibody Status and Serum Cytokine Levels in Type 1 Diabetes (English)

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

28 December 2023

0 references

1 reference

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

28 December 2023

author name string

Pejman Hanifi-Moghaddam

1

1 reference

2 December 2017

Simone Kappler

3

1 reference

2 December 2017

Jochen Seissler

4

1 reference

2 December 2017

Hubert Kolb

5

1 reference

2 December 2017

Nanette C. Schloot

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716743

28 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

http://diabetes.diabetesjournals.org/content/diabetes/52/5/1137.full.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716743

https://journals.org/diabetes/diabetes/article-pdf/52/5/1137/654934/db0503001137.pdf

28 December 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

https://diabetesjournals.org/diabetes/article-pdf/52/5/1137/654934/db0503001137.pdf

28 December 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

28 December 2023

1 reference

2 December 2017

volume

52

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

1137-1142

1 reference

The discovery of type 1 diabetes

2 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

28 December 2023

2

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Development of type 1 diabetes despite severe hereditary B-cell deficiency

28 December 2023

3

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

B-cell deficiency and type 1 diabetes

28 December 2023

4

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes

28 December 2023

7

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus

28 December 2023

8

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Prospective analysis of islet cell antibodies in children with type 1 (insulin-dependent) diabetes

28 December 2023

9

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Autoantibodies in human diabetes

28 December 2023

10

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group

28 December 2023

11

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients

28 December 2023

12

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis

28 December 2023

13

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes.

28 December 2023

17

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.

28 December 2023

19

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Prognostic factors for the course of beta cell function in autoimmune diabetes

28 December 2023

20

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease

28 December 2023

23

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry

28 December 2023

25

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Autoantibodies in relation to residual insulin secretion in children with IDDM.

28 December 2023

27

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults reflects different courses of beta cell damage

28 December 2023

28

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop

28 December 2023

29

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Heterophile antibodies segregate in families and are associated with protection from type 1 diabetes

28 December 2023

30

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina

28 December 2023

32

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Linear loss of insulin secretory capacity during the last six months preceding IDDM. No effect of antiedematous therapy with ketotifen.

28 December 2023

33

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Cytokines in sera from insulin-dependent diabetic patients at diagnosis

28 December 2023

34

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Cytokine plasma levels and lymphocyte subsets in patients with newly diagnosed insulin-dependent (type 1) diabetes mellitus before and following initial insulin treatment

28 December 2023

35

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Increased interleukin-12 plasma concentrations in both, insulin-dependent and non-insulin-dependent diabetes mellitus

28 December 2023

38

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors

28 December 2023

39

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Elevated serum IP-10 levels observed in type 1 diabetes

28 December 2023

40

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes

28 December 2023

41

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children

28 December 2023

42

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

Serum IFN-gamma and IL-10 levels are associated with disease progression in non-obese diabetic mice

28 December 2023

43

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1137

28 December 2023

Identifiers

1 reference

2 December 2017

1 reference